Principal Financial Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,161
Closed -$79.7K 2430
2024
Q2
$79.7K Buy
+11,161
New +$85.4K ﹤0.01% 2241
2024
Q1
Sell
-17,205
Closed -$112K 2512
2023
Q4
$112K Sell
17,205
-325,301
-95% -$2.1M ﹤0.01% 2257
2023
Q3
$3.23M Sell
342,506
-18,100
-5% -$218K ﹤0.01% 1662
2023
Q2
$5.04M Sell
360,606
-27,003
-7% -$460K ﹤0.01% 1522
2023
Q1
$7.27M Sell
387,609
-10,013
-3% -$164K 0.01% 1398
2022
Q4
$5.48M Buy
397,622
+14,392
+4% +$220K ﹤0.01% 1504
2022
Q3
$7.33M Sell
383,230
-4,096
-1% -$74.6K 0.01% 1339
2022
Q2
$5.91M Sell
387,326
-68,331
-15% -$1.01M ﹤0.01% 1495
2022
Q1
$9.28M Sell
455,657
-17,215
-4% -$351K 0.01% 1415
2021
Q4
$13.8M Buy
472,872
+386,148
+445% +$11.1M 0.01% 1213
2021
Q3
$1.87M Buy
86,724
+311
+0.4% +$7.51K ﹤0.01% 1881
2021
Q2
$2.22M Buy
86,413
+74,199
+607% +$1.58M ﹤0.01% 1883
2021
Q1
$223K Sell
12,214
-1,051
-8% -$17.5K ﹤0.01% 2356
2020
Q4
$153K Buy
+13,265
New +$121K ﹤0.01% 2329
2016
Q2
Sell
-5,679
Closed -$17K 2216
2016
Q1
$17K Buy
5,679
+840
+17% +$4.5K ﹤0.01% 2160
2015
Q4
$40K Hold
4,839
﹤0.01% 2162
2015
Q3
$35K Sell
4,839
-2,479
-34% -$20.7K ﹤0.01% 2161
2015
Q2
$67K Buy
7,318
+677
+10% +$6.51K ﹤0.01% 2159
2015
Q1
$63K Sell
6,641
-73
-1% -$703 ﹤0.01% 2130
2014
Q4
$65K Buy
+6,714
New +$67.6K ﹤0.01% 2142
2014
Q3
Sell
-7,661
Closed -$101K 2243
2014
Q2
$101K Buy
+7,661
New +$96.6K ﹤0.01% 2200

Other funds holding CDMO

Principal Financial Group's CDMO Position: Q3 2024 in Review

Principal Financial Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2024, closing a stake of 11,161 shares — an estimated $79.7K sold.

Principal Financial Group first reported a position in CDMO in Q2 2014 and held it in 21 quarters. The position peaked at $13.8M in Q4 2021. 171 funds tracked by Wall St. Rank hold CDMO as of Q3 2024.

  • Principal Financial Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Principal Financial Group sold 11,161 Avid Bioservices, Inc. Common Stock shares in Q3 2024, an estimated $79.7K.
  • Principal Financial Group first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2014 and held it in 21 quarters.
  • Principal Financial Group's Avid Bioservices, Inc. Common Stock position peaked at $13.8M in Q4 2021.
  • 171 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2024.

Based on Principal Financial Group's 13F filing for Q3 2024, filed 31 Oct 2024.